U-Chart Analysis:BrightPath Biotherapeutics Co., Ltd.:4594

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index BrightPath Biotherapeutics Co., Ltd. 4594 Medicals Mothers March 1, 2000 2015.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

BrightPath Biotherapeutics Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2019年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2018年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2017年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2016年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Cash and Cash Equivalents 0 0 6,529 4,951 2,555
Other Current AssetsHelp 3,328 5,162 371 289 236
Tangible Fixed AssetsHelp 97 91 266 116 49
Intangible Fixed AssetHelp 0 0 14 14 11
Investments and OthersHelp 49 52 56 39 26
Total AssetsHelp 3,475 5,304 7,236 5,408 2,877
Total Current LiabilitiesHelp 239 208 285 208 157
Total Long-term LiabilitiesHelp 0 0 0 0 0
Shareholder's EquityHelp 3,235 5,096 6,951 5,200 2,721
Total LiabilitiesHelp 3,475 5,304 7,236 5,408 2,877

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2019年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2018年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2017年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2016年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Amount of Sales 11 156 354 530 823
Total Sales 11 156 354 530 823
Cost of SalesHelp 4 71 315 525 772
Other Costs and RevenueHelp 1,865 1,969 1,616 1,118 1,045
Total CostsHelp 1,869 2,040 1,931 1,643 1,817
Net RevenueHelp 7 85 39 5 51
Earnings Before TaxHelp -1,860 -1,881 -1,573 -1,117 -993
Net IncomeHelp -1,858 -1,884 -1,577 -1,114 -994
Net Income -1,858 -1,884 -1,577 -1,114 -994

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2019年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2018年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2017年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2016年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Operating Cash Flow(OFC)Help -1,784 -1,458 -1,591 -1,068 -909
Investing Cash Flow(ICF)Help -107 -185 -112 -97 -32
Financing Cash FlowHelp 9 16 3,281 3,559 2,673
Exchange Difference of Cash and Cash EquivalentsHelp 0 -0 0 -0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -1,883 -1,627 1,578 2,395 1,732

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

BrightPath Biotherapeutics Co., Ltd.

Company where related level is highHelp

Toyama Chemical Co.,Ltd.
TSUMURA & CO.
RIBOMIC Inc.
MIZUHO MEDY CO.,LTD.
ASKA Pharmaceutical Co.,Ltd.
Daito Pharmaceutical Co.,Ltd.
LTT Bio-Pharma Co.,Ltd.
Sosei Group Corporation
DENKA SEIKEN Co.,Ltd.
OncoTherapy Science,Inc.